← Leaderboards
Renee Paula Wu
Washington University
$117,350
Attributed
$117,350
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2021–23$100K$75K$50K$25K$0
'21
'22
'23
Funding mix
By agency
NIH$117,350 · 1
By mechanism
F30$117,350 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- David G Denardo$14,438,310
- Emil R Unanue$30,520,501
- Paolo Provenzano$10,825,017
- Gwendalyn J Randolph$35,563,954
- John F Dipersio$33,235,840
Others in their field
Other Emerging Leaders on “Immune Checkpoint Blockade”
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$17,572,948
- Crystal Mackall · Children'S Hosp Of Philadelphia$10,785,733
- J. Silvio Gutkind · University Of California, San Diego$7,272,837
- Eti Yoles · Immunobrain Checkpoint Inc.$5,749,685
- Vinod P Balachandran · Sloan-Kettering Inst Can Research$5,168,008
- Sana D Karam · University Of Colorado Denver$4,851,223
Research focus
Immune Checkpoint BlockadeAntigensImmuneAntigen-Presenting CellsCareer DevelopmentCd4 Positive T LymphocytesCd8b1 GeneBasic ScienceCancer ImmunotherapyCellsCheckpoint TherapyClinical DevelopmentClinical PracticeCross PresentationCytotoxic Cd8 T CellsDendritic CellsDoctor Of PhilosophyCd8-Positive T-LymphocytesFaceFutureGenetic ModelsHistocompatibility Antigens Class IiImaging StudyImmunity
Grant awards (3)
The role of type 1 dendritic cells in CD4 and CD8 T cell anti-tumor immunity$52,694
F30 · FY2023 · CA · contact PI
The role of type 1 dendritic cells in CD4 and CD8 T cell anti-tumor immunity$32,686
F30 · FY2022 · CA · contact PI
The role of type 1 dendritic cells in CD4 and CD8 T cell anti-tumor immunity$31,970
F30 · FY2021 · CA · contact PI